AnaptysBio Inc reports results for the quarter ended in June - Earnings Summary

AnaptysBio

07/08/2023 23:29

* AnaptysBio Inc  ANAB.OQ  reported a quarterly adjusted
loss of
$1.50​​ per share for the quarter ended in June. The mean
expectation of six analysts for the quarter was for a loss of
$1.70 per share.
    * Revenue rose 184.5% to $3.46 million from a year ago;
analysts
expected $3.32 million. 
    * AnaptysBio Inc's reported EPS for the quarter was a loss
of
$1.50​.
    * The mean earnings estimate of analysts had fallen by
about 53.1%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * AnaptysBio Inc shares had fallen by 8.0% this quarter and
lost 39.6% so far this year.
    * The company reported a quarterly loss of $39.85 million.
    * Wall Street's median 12-month price target for AnaptysBio
Inc is
$28.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 4
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 7 at 10:29 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -1.70          -1.50          Beat
 Mar. 31 2023      -1.05          -1.58          Missed
 Dec. 31 2022      -0.96          -0.93          Beat
 Sep. 30 2022      -0.72          -1.18          Missed